Main menu

Oxford Nanopore Successfully Defends PacBio lawsuit


In November 2016, PacBio filed a Complaint with the International Trade Commission (“ITC”) alleging that Oxford Nanopore infringed two of PacBio’s patents and seeking to prevent Oxford Nanopore from selling its product in the United States.

Today, the ITC Commission has made a Final Determination affirming the Administrative Judge’s decision that Oxford Nanopore has not infringed PacBio’s patents. The ITC Commission also found that there has been no violation of 19 U.S.C. §1337 and terminated the ITC investigation.

Gordon Sanghera, CEO of Oxford Nanopore, said: “We are pleased that Pacific Biosciences has failed, in this action, to prevent Americans choosing and benefiting from Nanopore single molecule, real-time DNA sequencing”.

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag